Krebs Biochemicals & Industries Share Price
Start SIP in Krebs Biochemicals & Industries
Start SIPKrebs Biochemicals & Industries Performance
Day Range
- Low 77
- High 78
52 Week Range
- Low 60
- High 122
- Open Price0
- Previous Close78
- Volume30
Krebs Biochemicals & Industries Investment Rating
-
Master Rating:
-
Krebs Biocs.& Inds. has an operating revenue of Rs. 52.73 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of -39% needs improvement, ROE of 0% is poor and needs improvement. NULL The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 25 which is a POOR score indicating inconsistency in earnings, a RS Rating of 34 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 36 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 13 | 12 | 13 | 15 | 11 | 11 |
Operating Expenses Qtr Cr | 15 | 15 | 15 | 16 | 13 | 16 |
Operating Profit Qtr Cr | -2 | -3 | -2 | -1 | -3 | -5 |
Depreciation Qtr Cr | 2 | 2 | 2 | 2 | 2 | 1 |
Interest Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 |
Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Net Profit Qtr Cr | -5 | -6 | -5 | -4 | -5 | -7 |
Krebs Biochemicals & Industries Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- ₹83.40
- 50 Day
- ₹83.85
- 100 Day
- ₹81.53
- 200 Day
- ₹79.13
- 20 Day
- ₹85.44
- 50 Day
- ₹85.25
- 100 Day
- ₹80.26
- 200 Day
- ₹76.50
Krebs Biochemicals & Industries Resistance and Support
Resistance | |
---|---|
First Resistance | 78.89 |
Second Resistance | 79.48 |
Third Resistance | 79.91 |
RSI | 36.78 |
MFI | 0.00 |
MACD Single Line | -0.66 |
MACD | -1.80 |
Support | |
---|---|
First Support | 77.87 |
Second Support | 77.44 |
Third Supoort | 76.85 |
Krebs Biochemicals & Industries Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 1,276 | 127,600 | 100 |
Week | 2,831 | 283,050 | 100 |
1 Month | 11,047 | 1,104,740 | 100 |
6 Month | 78,368 | 2,456,046 | 31.34 |
Krebs Biochemicals & Industries Result Highlights
Krebs Biochemicals & Industries Synopsis
Market Cap | |
Sales | |
Shares in Float | |
No of funds | |
Yield |
Book Value | |
U/D Vol ratio | |
LTDebt / Equity | |
Alpha | |
Beta |
Krebs Biochemicals & Industries Shareholding Pattern
Owner Name |
---|
Krebs Biochemicals & Industries Management
Name | Designation |
---|
Krebs Biochemicals & Industries Forecast
Price Estimates
Krebs Biochemicals & Industries Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-08-07 | Quarterly Results | |
2024-05-21 | Audited Results | |
2024-02-12 | Quarterly Results | |
2023-11-08 | Quarterly Results | |
2023-08-09 | Quarterly Results |
Krebs Biochemicals & Industries FAQs
What is Share Price of Krebs Biochemicals & Industries ?
Krebs Biochemicals & Industries share price is ₹76 As on 08 October, 2024 | 13:34
What is the Market Cap of Krebs Biochemicals & Industries ?
The Market Cap of Krebs Biochemicals & Industries is ₹165.8 Cr As on 08 October, 2024 | 13:34
What is the P/E ratio of Krebs Biochemicals & Industries ?
The P/E ratio of Krebs Biochemicals & Industries is -8.5 As on 08 October, 2024 | 13:34
What is the PB ratio of Krebs Biochemicals & Industries ?
The PB ratio of Krebs Biochemicals & Industries is -1.4 As on 08 October, 2024 | 13:34
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.